Search results for ""Author Andrew Lakoff""
University of California Press Unprepared: Global Health in a Time of Emergency
Recent years have witnessed an upsurge in global health emergencies-from SARS to pandemic influenza to Ebola to Zika. Each of these occurrences has sparked calls for improved health preparedness. This book addresses the question, how did we become "unprepared?" Emerging disease has only recently come to be understood as a problem of preparedness. Andrew Lakoff follows the history of health preparedness from its beginnings in 1960s Cold War civil defense to the early twenty-first century, when international health authorities carved out a global space for governing potential outbreaks. Alert systems and trigger devices now link health authorities, government officials, and vaccine manufacturers, all of whom manage the possibility of a global pandemic. Funds have been devoted to cutting-edge research on pathogenic organisms, and a system of post hoc diagnosis analyzes sites of failed preparedness to find new targets for improvement. Yet, despite all these developments, the project of global health security continues to be unsettled by the prospect of surprise.
£72.00
Columbia University Press Disaster and the Politics of Intervention
Government plays a critical role in mitigating individual and collective vulnerability to disaster. Through measures such as disaster relief, infrastructure development, and environmental regulation, public policy is central to making societies more resilient. However, the recent drive to replace public institutions with market mechanisms has challenged governmental efforts to manage collective risk. The contributors to this volume analyze the respective roles of the public and private sectors in the management of catastrophic risk, addressing questions such as: How should homeland security officials evaluate the risk posed by terrorist attacks and natural disasters? Are market-based interventions likely to mitigate our vulnerability to the effects of climate change? What is the appropriate relationship between non-governmental organizations and private security firms in responding to humanitarian emergencies? And how can philanthropic efforts to combat the AIDS crisis ensure ongoing access to life-saving drugs in the developing world? More generally, these essays point to the way thoughtful policy intervention can improve our capacity to withstand catastrophic events. Additional Columbia / SSRC books on the Privatization of Risk and its Implications for Americans Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
£18.99
John Wiley and Sons Ltd Planning for the Wrong Pandemic
The fractious and disorganized governmental response to the coronavirus pandemic in the United States prompted many observers to ask why the country - which had the knowledge, resources, and plans to deal with such an event - was caught so unprepared when the crisis struck. In fact, as Andrew Lakoff shows, US officials had been planning for a pandemic for more than two decades, and many of these plans were implemented in the early stages of the pandemic. As authorities responded to the crisis, they relied on an already formulated set of concepts and tools that had been devised for managing a future emergency. These preexisting tools enabled officials to make sense of the event and to rapidly implement policies in response, but they also led to significant blind spots. What did these planning tools allowofficials to see, and what did they hide from view? And, as we assess the failures in our response to the pandemic and attempt to prepare for the next one, to what extent should we
£50.00
John Wiley and Sons Ltd Planning for the Wrong Pandemic
The fractious and disorganized governmental response to the coronavirus pandemic in the United States prompted many observers to ask why the country ? which had the knowledge, resources, and plans to deal with such an event ? was caught so unprepared when the crisis struck. In fact, as Andrew Lakoff shows, US officials had been planning for a pandemic for more than two decades, and many of these plans were implemented in the early stages of the pandemic. As authorities responded to the crisis, they relied on an already formulated set of concepts and tools that had been devised for managing a future emergency. These preexisting tools enabled officials to make sense of the event and to rapidly implement policies in response, but they also led to significant blind spots. What did these planning tools allowofficials to see, and what did they hide from view? And, as we assess the failures in our response to the pandemic and attempt to prepare for the next one, to what extent s
£16.82
Princeton University Press The Government of Emergency: Vital Systems, Expertise, and the Politics of Security
The origins and development of the modern American emergency stateFrom pandemic disease, to the disasters associated with global warming, to cyberattacks, today we face an increasing array of catastrophic threats. It is striking that, despite the diversity of these threats, experts and officials approach them in common terms: as future events that threaten to disrupt the vital, vulnerable systems upon which modern life depends.The Government of Emergency tells the story of how this now taken-for-granted way of understanding and managing emergencies arose. Amid the Great Depression, World War II, and the Cold War, an array of experts and officials working in obscure government offices developed a new understanding of the nation as a complex of vital, vulnerable systems. They invented technical and administrative devices to mitigate the nation’s vulnerability, and organized a distinctive form of emergency government that would make it possible to prepare for and manage potentially catastrophic events.Through these conceptual and technical inventions, Stephen Collier and Andrew Lakoff argue, vulnerability was defined as a particular kind of problem, one that continues to structure the approach of experts, officials, and policymakers to future emergencies.
£75.60
Princeton University Press The Government of Emergency: Vital Systems, Expertise, and the Politics of Security
The origins and development of the modern American emergency stateFrom pandemic disease, to the disasters associated with global warming, to cyberattacks, today we face an increasing array of catastrophic threats. It is striking that, despite the diversity of these threats, experts and officials approach them in common terms: as future events that threaten to disrupt the vital, vulnerable systems upon which modern life depends.The Government of Emergency tells the story of how this now taken-for-granted way of understanding and managing emergencies arose. Amid the Great Depression, World War II, and the Cold War, an array of experts and officials working in obscure government offices developed a new understanding of the nation as a complex of vital, vulnerable systems. They invented technical and administrative devices to mitigate the nation’s vulnerability, and organized a distinctive form of emergency government that would make it possible to prepare for and manage potentially catastrophic events.Through these conceptual and technical inventions, Stephen Collier and Andrew Lakoff argue, vulnerability was defined as a particular kind of problem, one that continues to structure the approach of experts, officials, and policymakers to future emergencies.
£25.20
Columbia University Press Biosecurity Interventions: Global Health and Security in Question
In recent years, new disease threats--such as SARS, avian flu, mad cow disease, and drug-resistant strains of malaria and tuberculosis--have garnered media attention and galvanized political response. Proposals for new approaches to "securing health" against these threats have come not only from public health and medicine but also from such fields as emergency management, national security, and global humanitarianism. This volume provides a map of this complex and rapidly transforming terrain. The editors focus on how experts, public officials, and health practitioners work to define what it means to "secure health" through concrete practices such as global humanitarian logistics, pandemic preparedness measures, vaccination campaigns, and attempts to regulate potentially dangerous new biotechnologies. As the contributions show, despite impressive activity in these areas, the field of "biosecurity interventions" remains unstable. Many basic questions are only beginning to be addressed: Who decides what counts as a biosecurity problem? Who is responsible for taking action, and how is the efficacy of a given intervention to be evaluated? It is crucial to address such questions today, when responses to new problems of health and security are still taking shape. In this context, this volume offers a form of critical and reflexive knowledge that examines how technical efforts to increase biosecurity relate to the political and ethical challenges of living with risk.
£37.80
Duke University Press Global Pharmaceuticals: Ethics, Markets, Practices
In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption.Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research.Contributors. Kalman Applbaum, João Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte
£87.30
Duke University Press Global Pharmaceuticals: Ethics, Markets, Practices
In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption.Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research.Contributors. Kalman Applbaum, João Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte
£24.99
